Skip to main content

Table 2 Co-linearity analysis of baseline variables and AIP index

From: Atherogenic index of plasma for non-diabetic, coronary artery disease patients after percutaneous coronary intervention: a prospective study of the long-term outcomes in China

Variables

Unstandardized coefficients

Standardized coefficients

t

Sig.

Collinearity statistics

B

Std.error

Beta

Tolerance

VIF

(Constant)

0.077

0.046

 

1.665

0.096

  

Demographic characteristics

 Age

 < 0.001

 < 0.001

− 0.009

− 1.769

0.077

0.648

1.542

 BMI

0.002

 < 0.001

0.02

4.286

 < 0.001

0.864

1.157

 Male

0.037

0.004

0.058

9.126

 < 0.001

0.445

2.249

 CCS

0.002

0.002

0.003

0.76

0.447

0.935

1.069

Coexisting conditions, %

 Hypertension

 < 0.001

0.003

− 0.001

− 0.146

0.884

0.746

1.341

 Dyslipidemia

0.01

0.002

0.019

4.261

 < 0.001

0.947

1.056

 Renal dysfunction

0.008

0.004

0.014

2.176

0.03

0.414

2.417

 Smoker

0.003

0.003

0.005

0.996

0.319

0.716

1.398

 Cerebrovascular diseases

− 0.004

0.004

− 0.004

− 0.891

0.373

0.953

1.049

 COPD

− 0.003

0.007

− 0.002

− 0.402

0.688

0.973

1.027

 Previous myocardial infarction

0.011

0.003

0.02

3.91

 < 0.001

0.687

1.456

 Previous CABG

0.004

0.009

0.002

0.48

0.631

0.921

1.086

 Previous PCI

− 0.007

0.003

− 0.011

− 2.44

0.015

0.852

1.174

 Peripheral vascular diseases

− 0.018

0.008

− 0.01

− 2.293

0.022

0.98

1.02

Lab test

 TG, mmol/l

0.197

0.002

0.732

81.299

 < 0.001

0.223

4.494

 TC, mmol/l

− 0.059

0.006

− 0.24

− 9.065

 < 0.001

0.026

38.825

 Creatine, umol/l

 < 0.001

 < 0.001

0.022

2.987

0.003

0.334

2.995

 Urine acid, umol/l

 < 0.001

 < 0.001

0.023

4.523

 < 0.001

0.706

1.417

 HbA1C, %

0.008

0.003

0.011

2.421

0.015

0.921

1.086

 HDL-C, mmol/l

− 0.417

0.007

− 0.459

− 58.223

 < 0.001

0.29

3.452

 LDL-C, mmol/l

0.077

0.007

0.269

11.467

 < 0.001

0.033

30.482

 Albumin, g/l

0.002

 < 0.001

0.029

6.001

 < 0.001

0.757

1.321

 LVEF, %

 < 0.001

 < 0.001

 < 0.001

0.018

0.986

0.81

1.235

Angiographic and procedural details

 Left main involved, %

0.006

0.005

0.005

1.128

0.259

0.854

1.171

 CTO

0.011

0.005

0.011

2.364

0.018

0.908

1.101

 Number of stents

− 0.001

0.001

− 0.004

− 0.887

0.375

0.769

1.3

 Diameters of stents

0.002

0.002

0.003

0.727

0.467

0.877

1.14

 SYNTAX score

 < 0.001

 < 0.001

0.006

1.087

0.277

0.666

1.502

 TVD, %

− 0.001

0.002

− 0.003

− 0.551

0.582

0.827

1.209

Medicine at discharge

 β-blocker

0.003

0.003

0.003

0.798

0.425

0.975

1.026

 Statin

− 0.013

0.006

− 0.009

− 2.196

0.028

0.988

1.012

 ACEI/ARB

0.003

0.002

0.005

1.119

0.263

0.796

1.256

 DAPT

− 0.006

0.009

− 0.003

− 0.648

0.517

0.99

1.011

 CCB

− 0.002

0.002

− 0.004

− 0.828

0.408

0.83

1.205

  1. AIP index, atherogenic index of plasma; BMI, body mass index; COPD, chronic obstructive pulmonary disease; CAD, coronary artery disease; CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; TG, triglycerides; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; HbA1C, hemoglobin A2C; LDL-C, low-density lipoprotein cholesterol; LVEF, left ventricular eject fraction; LAD, left anterior descending; RCA, right coronary artery; LCX, left circumflex; TVD, three vessel disease; CTO, chronic total occlusion; SYNTAX, synergy between PCI with TAXUSTM and cardiac surgery; ACEI, angiotensin converting enzyme inhibitors; ARB, angiotensin receptor blocker; DAPT, dual antiplatelet therapy; CCB, calcium channel blocker
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840